Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | HCA | ADBE |
|---|---|---|
| Price | $426.45 | $237.46 |
| Change today | ▼ 2.30% | ▼ 1.34% |
| Market cap | $92.33B | $92.42B |
| Return, 3 months | +10.0% | +20.8% |
| Return, year to date | -8.3% | -32.2% |
| Return, 1 year | +2.9% | -32.8% |
| P/E (TTM) | 14.3 | 13.3 |
| P/B | -13.9 | 7.9 |
| P/E percentile vs own 5y | 52nd | 5th |
| Dividend yield | 0.70% | – |
| Revenue growth (YoY, latest qtr) | +8.7% | +12.9% |
| Net profit growth (YoY) | +2.1% | +3.1% |
| Gross margin | 42.6% | 89.3% |
| Operating margin | 15.5% | 35.7% |
| Net margin | 8.8% | 28.0% |
| Return on equity | – | 61.9% |
| Analyst target vs. price | +6.6% | +15.2% |
| Analyst buy share | 62% | 38% |
| RSI (14) | 66 | 38 |
| 30-day volatility | 28.2% | 46.8% |
| Max drawdown, 1 year | -33.6% | -47.4% |
| Trend read | Leaning bullish | Strong downtrend |
| Analyst consensus | Buy | Hold |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.